Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant

ClinicalTrials.gov ID: NCT01503515

Public ClinicalTrials.gov record NCT01503515. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 25, 2026, 4:53 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Open-Label Trial of Caspofungin vs. Azole Prophylaxis for Patients at High-Risk for Invasive Fungal Infections (IFI) Following Allogeneic Hematopoietic Cell Transplantation (HCT)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This randomized phase III trial studies how well caspofungin acetate works compared to fluconazole or voriconazole in preventing fungal infections in patients following donor stem cell transplant. Caspofungin acetate, fluconazole, and voriconazole may be effective in preventing fungal infections in patients following donor stem cell transplant. It is not yet known whether caspofungin acetate is more effective than fluconazole or voriconazole in preventing fungal infections in patients following donor stem cell transplant.

Study identification

NCT ID
NCT01503515
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Children's Oncology Group
Network
Enrollment
292 participants

Conditions and interventions

Eligibility (public fields only)

Age range
3 Months to 20 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 20, 2013
Primary completion
Dec 30, 2019
Completion
Sep 29, 2021
Last update posted
Oct 15, 2024

2013 – 2021

United States locations

U.S. sites
46
U.S. states
26
U.S. cities
41
Facility City State ZIP Site status
Phoenix Childrens Hospital Phoenix Arizona 85016 —
Loma Linda University Medical Center Loma Linda California 92354 —
Children's Hospital and Research Center at Oakland Oakland California 94609-1809 —
Children's Hospital of Orange County Orange California 92868 —
Lucile Packard Children's Hospital Stanford University Palo Alto California 94304 —
Rady Children's Hospital - San Diego San Diego California 92123 —
UCSF Medical Center-Parnassus San Francisco California 94143 —
UCSF Medical Center-Mission Bay San Francisco California 94158 —
Alfred I duPont Hospital for Children Wilmington Delaware 19803 —
Nemours Children's Clinic-Jacksonville Jacksonville Florida 32207 —
Johns Hopkins All Children's Hospital St. Petersburg Florida 33701 —
Children's Healthcare of Atlanta - Egleston Atlanta Georgia 30322 —
University of Hawaii Cancer Center Honolulu Hawaii 96813 —
Kapiolani Medical Center for Women and Children Honolulu Hawaii 96826 —
Riley Hospital for Children Indianapolis Indiana 46202 —
University of Iowa/Holden Comprehensive Cancer Center Iowa City Iowa 52242 —
Norton Children's Hospital Louisville Kentucky 40202 —
Children's Hospital New Orleans New Orleans Louisiana 70118 —
Floating Hospital for Children at Tufts Medical Center Boston Massachusetts 02111 —
C S Mott Children's Hospital Ann Arbor Michigan 48109 —
Wayne State University/Karmanos Cancer Institute Detroit Michigan 48201 —
Helen DeVos Children's Hospital at Spectrum Health Grand Rapids Michigan 49503 —
University of Minnesota/Masonic Cancer Center Minneapolis Minnesota 55455 —
Mayo Clinic in Rochester Rochester Minnesota 55905 —
University of Mississippi Medical Center Jackson Mississippi 39216 —
Children's Mercy Hospitals and Clinics Kansas City Missouri 64108 —
Children's Hospital and Medical Center of Omaha Omaha Nebraska 68114 —
University of Nebraska Medical Center Omaha Nebraska 68198 —
Hackensack University Medical Center Hackensack New Jersey 07601 —
Roswell Park Cancer Institute Buffalo New York 14263 —
Montefiore Medical Center - Moses Campus The Bronx New York 10467 —
UNC Lineberger Comprehensive Cancer Center Chapel Hill North Carolina 27599 —
Duke University Medical Center Durham North Carolina 27710 —
Children's Hospital Medical Center of Akron Akron Ohio 44308 —
Rainbow Babies and Childrens Hospital Cleveland Ohio 44106 —
Cleveland Clinic Foundation Cleveland Ohio 44195 —
Nationwide Children's Hospital Columbus Ohio 43205 —
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 —
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 —
Children's Hospital of Pittsburgh of UPMC Pittsburgh Pennsylvania 15224 —
Vanderbilt University/Ingram Cancer Center Nashville Tennessee 37232 —
Medical City Dallas Hospital Dallas Texas 75230 —
UT Southwestern/Simmons Cancer Center-Dallas Dallas Texas 75390 —
Methodist Children's Hospital of South Texas San Antonio Texas 78229 —
Primary Children's Hospital Salt Lake City Utah 84113 —
Children's Hospital of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01503515, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 15, 2024 · Synced Sep 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01503515 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →